China National Medicines (SHSE:600511) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600511 China National Medicines Corp Ltd SHSE:600511
90 GF Score
Price ¥26.77
GF Value ¥32.09
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is China National Medicines SpecialCharges?

Special Charges only applies to banks.

SHSE:600511
90GF Score
China National Medicines Corp Ltd SHSE:600511
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China National Medicines (SHSE:600511) Overvalued in 2026?

Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued. The current stock price of ¥26.77 is trading 16.6% below its estimated GF Value™ of ¥32.09. GuruFocus considers China National Medicines to be Modestly Undervalued.

Key valuation signals for SHSE:600511:

  • SpecialCharges:
  • GF Value™: ¥32.09 vs. price of ¥26.77 (16.6% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China National Medicines Business Description

Address No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
90GF Score

Get the complete analysis for SHSE:600511

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.77
Price
¥32.09
GF Value